SAN FRANCISCO, March 16 /PRNewswire/ -- The Gynecologic Cancer Foundation (GCF) and the Claudia Cohen Research Foundation announce today that Dr. Paul Goodfellow has been selected as the first recipient of the $50,000 GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher. The prize is being presented at the Society of Gynecologic Oncologists (SGO) 41st Annual Meeting on Women's Cancer, meeting in San Francisco March 14-17, 2010.
Dr. Goodfellow has made important contributions to the improvement of women's healthcare through his laboratory research efforts, and his role in mentoring gynecologic oncologists in basic science and in translational research. Dr. Goodfellow's research is focused largely on the genetic and epigenetic events that are associated with the initiation and progression of endometrial cancer. Over the past 15 years he has established a strong research group at Siteman Cancer Center, Washington University School of Medicine and at the national level. His long-standing efforts in elucidating both the causes and consequences of defective DNA mismatch repair in endometrial cancer have significantly advanced knowledge about the most common gynecologic cancer.
Each year over 40,000 women are diagnosed with endometrial cancer and over 7,700 die.
|SOURCE Gynecologic Cancer Foundation; Claudia Cohen Research Foundation|
Copyright©2010 PR Newswire.
All rights reserved